HCV Post-Exposure Prophylaxis
Antiviral post-exposure prophylaxis is NOT recommended for hepatitis C virus (HCV) exposures 1.
Immediate Management After HCV Exposure
After a potential HCV exposure, focus on immediate wound care and establishing a monitoring protocol rather than initiating prophylactic antivirals:
Immediate Actions (Within 48 Hours)
- Wash wounds and skin with soap and water
- Flush mucous membranes with water
- Test the source patient for anti-HCV (and HCV RNA if available or if high-risk behaviors present) 2
- Baseline testing of exposed healthcare worker for anti-HCV with reflex to HCV RNA if positive 2
Monitoring Protocol
The monitoring strategy depends on whether you pursue early detection or standard surveillance:
Option 1: Early Detection Protocol (Preferred)
- HCV RNA at 3-6 weeks post-exposure 2
- If negative at 3-6 weeks, perform final anti-HCV at 4-6 months 2
Option 2: Standard Surveillance
- Baseline anti-HCV and ALT within 7-14 days 3
- Follow-up anti-HCV and ALT at 4-6 months 1
- Consider HCV RNA at 4-6 weeks if earlier diagnosis desired 1
Why No Prophylaxis?
The evidence is clear and consistent across multiple guidelines:
- Low transmission risk: HCV transmission occurs in only 0.2%-10% of needlestick exposures 4
- No proven benefit: A pilot study of peginterferon alfa-2b prophylaxis showed no HCV transmission in either treated or untreated groups, providing no evidence to support routine prophylaxis 4
- Direct-acting antivirals (DAAs) not indicated: Despite the availability of highly effective DAAs, there are no published studies supporting their use for post-exposure prophylaxis, and such use would not be cost-effective 5, 6
- Treatment of acute infection is effective: If infection occurs, early treatment during the acute phase is highly successful, making prophylaxis unnecessary 7
Critical Pitfalls to Avoid
- Do not prescribe DAAs as prophylaxis - This is not evidence-based and wastes resources 5, 6
- Do not test discarded needles or syringes for virus contamination 1
- Do not skip source patient testing - Knowing the source status guides the intensity of follow-up
- Ensure follow-up completion - Most exposed healthcare workers are lost to follow-up; establish a robust tracking system 1
When HCV Infection is Detected
If the exposed person tests positive for HCV RNA:
- Refer immediately to hepatology/infectious disease care 2
- Early treatment of acute HCV is highly effective and can prevent chronic infection
- Modern pan-genotypic DAA regimens achieve cure rates >95% even in acute infection
Special Considerations
Mucous membrane exposures to blood from unknown HCV status sources pose minimal risk and generally require no action unless exposure to an HCV-infected source is known or highly likely 3.
Mass casualty events: Testing and follow-up should be arranged as part of discharge planning rather than in the acute setting 3.